TY - JOUR
T1 - Human embryonic stem cells derived keratinocyte as an in vitro research model for the study of immune response
AU - Kidwai, Fahad Karim
AU - Jokhun, Doorgesh Sharma
AU - Movahednia, Mohammad Mehdi
AU - Yeo, Jin Fei
AU - Tan, Kai Soo
AU - Cao, Tong
PY - 2013/9
Y1 - 2013/9
N2 - Background: The innate immune response (IMR) is critical for the oral mucosa due to their continuous exposure to various oral pathogens. Keratinocytes play important role in IMR. Therefore, to date, keratinocytes from different sources have been used as in vitro research model for the study of IMR. However, current keratinocyte research models are hampered by the limited supply, patients' dependency and batch to batch variation. Therefore, in this study, we demonstrated the use of human embryonic stem cells (hESCs) derived keratinocytes (H9-Kert) as an alternative research model for the study of IMR. Methods: The expression kinetics of toll-like receptor (TLR) 2, TLR 4, interleukin (IL) -6, IL-8, inducible nitric oxide synthase (iNOS) and tumour necrosis factor-alpha (TNF-α), in H9-Kert and immortalized human keratinocyte cell line (HaCaT) were analysed at mRNA levels by both reverse transcription polymerase chain reaction (RT-PCR) and quantitative real-time RT-PCR. The activation of the inflammatory transcription factor nuclear factor kappa-b (NFK{green}B) was assayed in these cells by transiently transfecting the cells with NFK{green}B reporter plasmid. Activation of NFK{green}B following treatment with heat-killed Porphyromonas gingivalis (P. gingivalis), an oral pathogen, was determined by assaying for the reporter, secreted alkaline phosphatase activity. Results: The expression of TLRs, cytokines and activation of NFK{green}B following bacterial stimulation showed in both H9-Kert and the widely used HaCaT keratinocyte cell line was similar. Conclusion: Overall, our results support the potential application of hESCs as an alternative limitless cell source for primary keratinocytes which can be used as consistent and dependable research tool with minimum variations and no donor's dependency.
AB - Background: The innate immune response (IMR) is critical for the oral mucosa due to their continuous exposure to various oral pathogens. Keratinocytes play important role in IMR. Therefore, to date, keratinocytes from different sources have been used as in vitro research model for the study of IMR. However, current keratinocyte research models are hampered by the limited supply, patients' dependency and batch to batch variation. Therefore, in this study, we demonstrated the use of human embryonic stem cells (hESCs) derived keratinocytes (H9-Kert) as an alternative research model for the study of IMR. Methods: The expression kinetics of toll-like receptor (TLR) 2, TLR 4, interleukin (IL) -6, IL-8, inducible nitric oxide synthase (iNOS) and tumour necrosis factor-alpha (TNF-α), in H9-Kert and immortalized human keratinocyte cell line (HaCaT) were analysed at mRNA levels by both reverse transcription polymerase chain reaction (RT-PCR) and quantitative real-time RT-PCR. The activation of the inflammatory transcription factor nuclear factor kappa-b (NFK{green}B) was assayed in these cells by transiently transfecting the cells with NFK{green}B reporter plasmid. Activation of NFK{green}B following treatment with heat-killed Porphyromonas gingivalis (P. gingivalis), an oral pathogen, was determined by assaying for the reporter, secreted alkaline phosphatase activity. Results: The expression of TLRs, cytokines and activation of NFK{green}B following bacterial stimulation showed in both H9-Kert and the widely used HaCaT keratinocyte cell line was similar. Conclusion: Overall, our results support the potential application of hESCs as an alternative limitless cell source for primary keratinocytes which can be used as consistent and dependable research tool with minimum variations and no donor's dependency.
KW - Human embryonic stem cells
KW - Human embryonic stem cells derived keratinocyte
KW - Innate immunity
KW - Toll-like receptors
UR - http://www.scopus.com/inward/record.url?scp=84883554960&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84883554960&partnerID=8YFLogxK
U2 - 10.1111/jop.12054
DO - 10.1111/jop.12054
M3 - Article
C2 - 23464791
AN - SCOPUS:84883554960
SN - 0904-2512
VL - 42
SP - 627
EP - 634
JO - Journal of Oral Pathology and Medicine
JF - Journal of Oral Pathology and Medicine
IS - 8
ER -